Dan Wen

469 total citations
23 papers, 366 citations indexed

About

Dan Wen is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dan Wen has authored 23 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Dan Wen's work include Cancer Mechanisms and Therapy (3 papers), Inflammasome and immune disorders (3 papers) and Circular RNAs in diseases (3 papers). Dan Wen is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Inflammasome and immune disorders (3 papers) and Circular RNAs in diseases (3 papers). Dan Wen collaborates with scholars based in China, United States and Australia. Dan Wen's co-authors include Lifen Qian, Guanzhong Wu, Qian Yu, Rod Cupples, Beverly S. Adler, R Basu, Phillip Buckhaults, Nevis Fregien, Mohamed Shoreibah and Jasminder Weinstein and has published in prestigious journals such as Journal of Biological Chemistry, Life Sciences and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Dan Wen

19 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Wen China 10 259 95 68 60 60 23 366
Karine Aupeix France 8 266 1.0× 152 1.6× 32 0.5× 27 0.5× 34 0.6× 8 480
W. Roy Smythe United States 13 351 1.4× 34 0.4× 46 0.7× 145 2.4× 59 1.0× 21 567
Kaoru Morishita Japan 10 163 0.6× 118 1.2× 35 0.5× 21 0.3× 60 1.0× 18 357
Anca Năstase Romania 9 198 0.8× 66 0.7× 23 0.3× 51 0.8× 78 1.3× 17 309
M Katano Japan 11 245 0.9× 117 1.2× 20 0.3× 65 1.1× 139 2.3× 19 539
Binyan Lin China 7 178 0.7× 53 0.6× 14 0.2× 142 2.4× 40 0.7× 9 456
Shaolin Ma China 11 199 0.8× 42 0.4× 16 0.2× 27 0.5× 75 1.3× 32 363
Asmitananda Thakur China 15 356 1.4× 69 0.7× 15 0.2× 73 1.2× 198 3.3× 25 507
Lin‐wen Wu China 12 225 0.9× 35 0.4× 31 0.5× 69 1.1× 82 1.4× 18 381

Countries citing papers authored by Dan Wen

Since Specialization
Citations

This map shows the geographic impact of Dan Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Wen more than expected).

Fields of papers citing papers by Dan Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Wen. The network helps show where Dan Wen may publish in the future.

Co-authorship network of co-authors of Dan Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Wen. A scholar is included among the top collaborators of Dan Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Wen. Dan Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Dan, Qi Wang, Zilei Wang, et al.. (2025). Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer. Molecular Pharmaceutics. 22(4). 2276–2286.
3.
Ma, Xiaokun, Teli Liu, Rui Guo, et al.. (2024). Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1406–1421.
4.
Wen, Dan, et al.. (2022). HOXD9 aggravates the development of cervical cancer by transcriptionally activating HMCN1. Panminerva Medica. 64(4). 532–536. 11 indexed citations
5.
Wen, Dan, et al.. (2022). Recent advances in the development of transplanted colorectal cancer mouse models. Translational research. 249. 128–143. 9 indexed citations
6.
Li, Li, et al.. (2022). Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR-193a-5p/GPX4. Journal of Oncology. 2022. 1–11. 34 indexed citations
7.
Wen, Dan, et al.. (2021). Preventive and therapeutic effect of intraportal oridonin on BALb/c nude mice hemispleen model of colon cancer liver metastasis. Translational Cancer Research. 10(3). 1324–1335. 5 indexed citations
8.
Wen, Dan, et al.. (2021). Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(6). 1263–1274. 6 indexed citations
9.
Wen, Dan, et al.. (2021). Oridonin Enhances the Anti-Metastasis Effect of Oxaliplatinliplatin on Colorectal Cancer Liver Metastasis. Bulletin of Experimental Biology and Medicine. 172(1). 26–32. 5 indexed citations
10.
Wen, Dan, et al.. (2021). Transmembrane Protease TMPRSS4 Promotes the Formation and Development of Mismatch Repair Deficient Colon Cancer Liver Metastasis. Bulletin of Experimental Biology and Medicine. 171(2). 242–246.
11.
Wen, Dan, et al.. (2020). [Construction of ACT-1 human undifferentiated thyroid cancer cell line with knockout of axis inhibition protein 1 (AXIN1) gene using CRISPR/Cas9].. PubMed. 36(5). 419–424. 1 indexed citations
12.
Lin, Shiyu, et al.. (2020). miR-597-3p inhibits invasion and migration of thyroid carcinoma SW579 cells by targeting RAB23. Endokrynologia Polska. 72(1). 22–28. 4 indexed citations
13.
Wen, Dan, Xianliang Zhou, Xin Du, Jianzeng Dong, & Changsheng Ma. (2020). Association of interleukin-18 gene polymorphisms with Takayasu arteritis in a Chinese Han population. Chinese Medical Journal. 133(19). 2315–2320. 5 indexed citations
14.
Wen, Dan, et al.. (2020). Long noncoding RNAs SET‐binding factor 2‐antisense RNA1 promotes cell growth through targeting miR‐431‐5p/CDK14 axis in human papillary thyroid cancer. The Kaohsiung Journal of Medical Sciences. 36(10). 808–816. 9 indexed citations
15.
Yu, Qian, et al.. (2019). Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway. Life Sciences. 225. 1–7. 71 indexed citations
16.
Wang, Sha, et al.. (2014). Effect of retinoic acid on the tight junctions of the retinal pigment epithelium-choroid complex of guinea pigs with lens-induced myopia in vivo. International Journal of Molecular Medicine. 33(4). 825–832. 25 indexed citations
17.
Wen, Dan, Xin Du, Shaoping Nie, Jianzeng Dong, & Changsheng Ma. (2014). Association of Connexin37 C1019T with myocardial infarction and coronary artery disease: a meta-analysis. Experimental Gerontology. 58. 203–207. 10 indexed citations
18.
Wang, Linping, Linggen Gao, Xian‐Liang Zhou, et al.. (2012). Genetic diagnosis of Liddle's syndrome by mutation analysis of SCNN1B and SCNN1G in a Chinese family.. PubMed. 125(8). 1401–4. 11 indexed citations
19.
Gao, Linggen, Qunxia Mao, Dan Wen, et al.. (2011). The effect of beta‐blocker therapy on progressive aortic dilatation in children and adolescents with Marfan’s syndrome: a meta‐analysis. Acta Paediatrica. 100(9). e101–5. 29 indexed citations
20.
Zhou, Guoying, Dingsheng Lin, Chunzi Liang, et al.. (1999). [Expression of P53 protein in premalignant lesion and carcinoma of larynx].. PubMed. 30(3). 265–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026